Research

The Research Program seeks to maximize the impact of its research investment by focusing in three principle disease areas — OA, RA and JA.

Rheumatoid Arthritis

Rheumatoid Arthritis

Knowing the right treatment for each person. Today, Rheumatoid Arthritis (RA) affects 1.5 million people in the U.S. – most of them women.

Osteoarthritis

Osteoarthritis

Finding a way to stop osteoarthritis. Americans spend $128 billion on arthritis-related health care costs each year. Much of that expense goes toward the treatment of OA.

Juvenile Arthritis

Juvenile Arthritis

Despite the common yet inaccurate belief that arthritis is “an old person’s” disease, 300,000 American children endure the debilitating pain and severely disabling effects of juvenile arthritis (JA).

Research Grants

Research Grants

The Research Grant Program seeks to maximize the impact of its research investment by focusing in three principal disease areas – Osteoarthritis, Rheumatoid Arthritis and Juvenile Arthritis.

Tools and Resources

Tools and Resources

To help you see and understand where your donations go and the impact of the Research Program, the foundation launched SciVal Experts, a research profiling and networking tool.

Research News

Choice of Footwear May Help Knee OA

Choice of Footwear May Help Knee OA

Arthritis Foundation funded researcher, Dr. Najia Shakoor, finds that flexible-soled shoes may work better than shoes with stiffer soles for people with osteoarthritis.

ACL Feasibility Study Could Revolutionize Treatment for Osteoarthritis

ACL Feasibility Study Could Revolutionize Treatment for Osteoarthritis

By studying anterior cruciate ligament (ACL) tears in the knee, a major risk factor for developing osteoarthritis, researchers seek to discover tools and treatments to detect and reverse OA before symptoms ever appear.

Developing Treatments for JA

Developing Treatments for JA

The Childhood Arthritis and Rheumatology Research Alliance has created consensus treatment plans to improve and standardize care of pediatric rheumatic diseases.